BAILII
British and Irish Legal Information Institute


Freely Available British and Irish Public Legal Information

[Home] [Databases] [World Law] [Multidatabase Search] [Help] [Feedback]

United Kingdom Intellectual Property Office Decisions


You are here: BAILII >> Databases >> United Kingdom Intellectual Property Office Decisions >> PXG Pharma (Trade Mark: Opposition) [2022] UKIntelP o105422 (1 December 2022)
URL: http://www.bailii.org/uk/cases/UKIntelP/2022/o105422.html
Cite as: [2022] UKIntelP o105422

[New search] [Printable PDF version] [Help]

PXG Pharma (Trade Mark: Opposition) [2022] UKIntelP o105422 (1 December 2022)

Trade mark decision

BL Number
O/1054/22
Decision date
1 December 2022
Hearing Officer
Mr A James
Mark
PXG Pharma
Classes
03, 05, 08, 10, 16, 21, 29, 30, 32, 35

Grounds

  • Sections 5(1), 5(2) and 5(3) Earlier Trade Marks - Distinctive and dominant components
  • Sections 5(1), 5(2) and 5(3) Average Customer - Consumer attention levels
  • Sections 5(1), 5(2) and 5(3) Dilution Cases - Reputation
  • Section 5(4) Earlier Rights - Passing off (Issues arising from Registry proceedings)
  • Procedural Issues - Costs – litigants in person, actual, security for

Full decision O/1054/22 PDF document388Kb


About BAILII - FAQ - Copyright Policy - Disclaimers - Privacy Policy amended on 25/11/2010